About 2 million breathing devices have been sold in Russia over the past decade. The best known is the Frolov breathing device. It has been employed to conquer a large number of chronic health disorders.
Some other facts about successes of the Frolov respiration device:
- They are supported or approved by over 100 GPs, MDs and other health care professionals
- More than 200 breathing clubs have been formed in the largest cities of Russia – evaluated in over 25 successful published clinical pilot trials and approbations
- They have been tried on myocardial infarction, bronchial asthma with weakness of respiratory muscles, acute bronchitis, emphysema, angina pectoris, digestive problems, chronic bronchitis, hypertension, obesity, asthma exacerbations, arthritis, stroke, children asthma, diabetes, psychological disorders, cystic fibrosis and many other chronic disorders
- Published clinical pilot trials and approbations discovered its efficiency for less wheezing, reduced coughing, reduced inflammation in airways, diminished shortness of breath, improved digestion and partial or complete normalisation of the FEV1 (forced expiratory volume in 1 s electrocardiogram, renovasography measurements, body antioxidant defence, heart rate, blood pressure, cardiointervalography results, and other important biochemical parameters.
- They are approved by the FDA and patented in the USA (USA Patent No. 5,755,640 from May 26,